Abu Dhabi Investment Authority (ADIA) is investing $200 million for a 3% stake in Meril, an Indian medical device maker, valuing the company at $6.6 billion.
The transaction, announced Monday, is subject to clearance from India’s competition regulator. Once completed, Meril will count two major global investors on its cap table alongside existing investor Warburg Pincus.
Founded by the Bilakhia Group, Meril is a global innovator in medical technology (MedTech), with a strong focus on clinically advanced solutions across multiple specialties including Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics and Surgical Robotics.
Speaking about the investment, Sanjeev Bhatt, Senior Vice President of Strategy, Meril said, “This investment by ADIA reinforces confidence in Meril’s long term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our R&D and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.”
